Journal Article

DZNE-2020-05452

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN).

Hogarth, P. ; Kurian, M. A. ; Gregory, A. ; Csányi, B. ; Zagustin, T. ; Kmiec, T. ; Wood, P. ; Klucken, A. ; Scalise, N. ; Sofia, F. ; Klopstock, T.DZNE* ; Zorzi, G. ; Nardocci, N. ; Hayflick, S. J. (Corresponding author)

2017
Academic Press Orlando, Fla.

This record in other databases:    

Please use a persistent id in citations: doi:10.1016/j.ymgme.2016.11.004

Keyword(s): Adolescent (MeSH) ; Adult (MeSH) ; Child (MeSH) ; Humans (MeSH) ; Iron Chelating Agents: therapeutic use (MeSH) ; Pantothenate Kinase-Associated Neurodegeneration: diagnosis (MeSH) ; Pantothenate Kinase-Associated Neurodegeneration: drug therapy (MeSH) ; Pantothenate Kinase-Associated Neurodegeneration: genetics (MeSH) ; Pantothenic Acid: therapeutic use (MeSH) ; Phosphotransferases (Alcohol Group Acceptor): genetics (MeSH) ; Practice Guidelines as Topic (MeSH) ; Iron Chelating Agents ; Pantothenic Acid ; Phosphotransferases (Alcohol Group Acceptor) ; pantothenate kinase

---

Contributing Institute(s):

1. Clinical Dementia Research München (Clinical Dementia Research München)

Research Program(s):

1. 344 - Clinical and Health Care Research (POF3-344) (POF3-344)

Appears in the scientific report 2017

---

Database coverage:
; BIOSIS Previews ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; Ebsco Academic Search ; IF < 5 ; JCR ; Nationallizenz ; SCOPUS ; Web of Science Core Collection

---